Chargement en cours...
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
Ulcerative colitis (UC) is a chronic and relapsing inflammatory intestinal disease. Although the morbidity of UC has increased notably in recent years, effective therapeutic treatment remains unsatisfactory. Astragaloside IV (ASI), a monomeric compound isolated from the traditional Chinese medicine...
Enregistré dans:
| Publié dans: | Exp Ther Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755457/ https://ncbi.nlm.nih.gov/pubmed/31572532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7907 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|